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Abstract: Over the past decade, Deep Artificial Neural Networks (DNNs) have become the
state-of-the-art algorithms in Machine Learning (ML), speech recognition, computer vision, natural
language processing and many other tasks. This was made possible by the advancement in Big Data,
Deep Learning (DL) and drastically increased chip processing abilities, especially general-purpose
graphical processing units (GPGPUs). All this has created a growing interest in making the most
of the potential offered by DNNs in almost every field. An overview of the main architectures
of DNNs, and their usefulness in Pharmacology and Bioinformatics are presented in this work.
The featured applications are: drug design, virtual screening (VS), Quantitative Structure–Activity
Relationship (QSAR) research, protein structure prediction and genomics (and other omics) data
mining. The future need of neuromorphic hardware for DNNs is also discussed, and the two most
advanced chips are reviewed: IBM TrueNorth and SpiNNaker. In addition, this review points out
the importance of considering not only neurons, as DNNs and neuromorphic chips should also
include glial cells, given the proven importance of astrocytes, a type of glial cell which contributes
to information processing in the brain. The Deep Artificial Neuron–Astrocyte Networks (DANAN)
could overcome the difficulties in architecture design, learning process and scalability of the current
ML methods.
Keywords: artificial neural networks; artificial neuron–astrocyte networks; tripartite synapses; deep
learning; neuromorphic chips; big data; drug design; Quantitative Structure–Activity Relationship;
genomic medicine; protein structure prediction
1. Introduction
Machine Learning (ML) is a subfield of Artificial Intelligence which attempts to endow computers
with the capacity of learning from data, so that explicit programming is not necessary to perform a
task. ML algorithms allow computers to extract information and infer patterns from the record data so
computers can learn from previous examples to make good predictions about new ones. ML algorithms
have been successfully applied to a variety of computational tasks in many fields. Pharmacology and
bioinformatics are “hot topics” for these techniques because of the complexity of the tasks. For example,
in bioinformatics, ML methods are applied to predict protein structure and genomics (and other omics)
data mining. In the case of pharmacology, these methods are used to discover, design and prioritize
bioactive compounds, which can be candidates for new drugs [1]. Moreover, ML can be helpful to
analyze clinical studies of these compounds, optimize drug forms, and evaluate drug quality [2,3].
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The development of a drug has different phases; in the first step a set of molecular representation,
or descriptors, are selected. These descriptors represent the relevant properties of the molecules of
interest. The encoded molecules are compared to one another using a metric or scoring scheme. Next,
the data set is usually divided into three parts: training set, validation set and test set. The final
step involves the use of ML methods to extract features of interest that can help to differentiate
active compounds from inactive ones. Quantitative Structure-Activity Relationship (QSAR) is used
to find relationships between the structure of a compound and its activity, both biological and
physicochemical [4]. There are similar mathematical models that look for other relationships, such as
Quantitative Structure-Property Relationship (QSPR), Quantitative Structure–Toxicity Relationship
(QSTR) or Quantitative Structure–Pharmacokinetic Relationship (QSPkR) [5].
It is of major importance to select the right descriptors to extract valuable features from the input
data. The accuracy of these data, and the statistical tools used, are also relevant in the development
process [4]. Over the past decades, the ML techniques used in pharmaceutical and bioinformatics
applications were “shallow”, with only a few layers of feature transformations. Some of the most
used algorithms are: principle component analysis, k-means clustering, decision trees, Support Vector
Machines (SVMs) and Artificial Neural Networks (ANNs) [1,4].
The ANNs have been applied to pharmacology and bioinformatics for more than two decades.
Historically, the first report on the application of ANNs in these fields was published by Qian and
Sejnowski in 1988 [6]. They used ANNs for the prediction of the protein secondary structure. In 1990,
Aoyama et al. presented the first report on the application of ANNs to QSAR [7], whereas in 1993,
Wikel and Dow disclosed an application of the ANNs in the description of the pruning step of QSAR [8].
An example of an effective application of ANNs was with a data set of HIV-1 reverse transcriptase
inhibitors, in the descriptor selection process [9]. Kovalishyn et al. developed a pruning method
based on an ANN trained with the Cascade-Correlation learning method in 1998 [10]. These are some
examples of early applications of ANNs, but a huge advance had been made in these ML techniques.
To get a historical perspective, and to understand in detail the applications of ANNs, and other ML
algorithms, to pharmacology and bioinformatics, the reader is referred to these reviews [1–5,11–18].
Although ANNs were soon identified as useful tools for pharmacology and bioinformatics, SVMs
and random forest made great progress, dominating the field until recently. The reasons of the limited
application of ANNs were: “scarcity” of data, difficulty to understand the features extracted, and the
computational cost entailed by the network training. Over the past decade, DNNs have become the
state-of-the-art algorithms of ML in speech recognition, computer vision, natural language processing
and many other tasks. This was made possible by the advancement in Big Data, Deep Learning and
the exponential increase of the chip processing capabilities, especially GPGPUs.
The Big Data term can be understood by the exponential grow of data, since 90% of the data in
the world today has been created in the last two years alone. This data explosion is transforming
the way research is conducted, making it necessary to acquire skills in the use of Big Data to solve
complex problems related to scientific discovery, biomedical research, education, health, national
security, among others. In genomic medicine, this can be illustrated by the fact that the first sequenced
human genome cost nearly $3 billion, today it can be done for less than $1000. In cancer research,
data produced by researchers can be analyzed to support this research. Multiple protein sequences
can be analyzed to determine the evolutionary links and predict molecular structures. In Medicine
and Bioinformatics, there are numerous opportunities to make the most of the huge amount of data
available. Some of the challenges include developing safer drugs, reducing the costs of clinical trials,
as well as exploring new alternatives, such novel antibiotics, to fight against resistant microorganisms;
and finally, extracting value information from the vast amount of data generated by the public health.
In order to make the most of the huge amount of information available, different data analysis
software frameworks, such as Hadoop, have been created [19]. These frameworks allow the use of
simple programming models to process large data sets from thousands of computers. Figure 1 shows
a general workflow for Big Data.
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DL is a new area of ML research, which is inspired by the brain and data abstraction created by 
multiple stages of processing. The DL algorithms allow high-level abstraction from the data, and this 
is helpful for automatic features extraction and for pattern analysis/classification. A key aspect of DL 
was the development of unsupervised training methods to make the best use of the huge amount of 
unlabeled data available [11]. Deep Feedforward Neural Networks (DFNN), Deep Belief Networks 
(DBN), Deep AutoEncoder Networks, Deep Boltzmann Machines (DBM), Deep Convolutional 
Neural Networks (DCNN) and Deep Recurrent Neural Networks (DRNN) are examples of artificial 
neural networks with deep learning. They have been applied to fields such as computer vision, 
automatic speech recognition or natural language processing, where they have been shown to 
produce state-of-the-art results on multiples tasks, (see Table 1). The idea of building DNNs is not 
new but there was a historical problem, called “vanishing gradient problem” [20]. It is difficult to 
train these types of large networks with several layers when the backpropagation algorithm is used 
to optimize the weights, because the gradients which propagate backwards rapidly diminish in 
magnitude as the depth of the network increases, thus the weights in the early layers changes very 
slowly [21]. DNNs have become the leading ML technology for a range of applications since 
Geoffrey Hinton examined the issues around training large networks [22], and came up with a new 
approach that had consequences for the cost of training of these networks [23,24]. Over the past 
decade, a variety of algorithms and techniques have been developed to design and train different 
architectures of DNN [25–31]. 
Table 1. Deep Artificial Neural Networks Achievements. Adapted from a slide developed by Yann 
Lecun, Facebook and NYU [32]. 
Task (Year) Competition 
Handwriting recognition (2009) MNIST (many), Arabic HWX (IDSIA) 
Volumetric brain image segmentation (2009) Connectomics (IDSIA, MIT) 
OCR in the Wild (2011) StreetView House Numbers (NYU and others) 
Traffic sign recognition (2011) GTSRB competition (IDSIA, NYU) 
Human Action Recognition (2011) Hollywood II dataset (Stanford) 
Breast cancer cell mitosis detection (2011) MITOS (IDSIA) 
Object Recognition (2012) ImageNet competition (Toronto) 
Scene Parsing (2012) Stanford bgd, SiftFlow, Barcelona datasets (NYU) 
Speech Recognition (2012) Acoustic modeling (IBM and Google) 
Asian handwriting recognition (2013) ICDAR competition (IDSIA) 
Pedestrian Detection (2013) INRIA datasets and others (NYU) 
Scene parsing from depth images (2013) NYU RGB-D dataset (NYU) 
Playing Atari games (2013) 2600 Atari games (Google DeepMind Technologies) 
Game of Go (2016) 
AlphaGo vs. Human World Champion  
(Google DeepMind Technologies) 
Finally, GPUs were created to process graphics, especially for gaming and design. Some 
researchers programmed GPUs using API, but this was a difficult task [33]. In 2007, NVIDIA 
published “Compute Unified Device Architecture” (CUDA) [34], a programming language based on 
C to optimize GPGPU application. CUDA allows researchers to make the most of the computing 
capabilities of GPUs for parallel programming. Nowadays, almost every supercomputer in the 
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DL is a new area of ML research, which is inspired by the brain and data abstraction created
by multiple stages of processing. The DL algorithms allow high-level abstraction from the data,
and this is helpful for automatic features extraction and for pattern analysis/classification. A key
aspect of DL was the development of unsupervised training methods to make the best use of
the huge amount of unlabeled data available [11]. Deep Feedforward Neural Networks (DFNN),
Deep Belief Networks (DBN), Deep AutoEncoder Networks, Deep Boltzmann Machines (DBM),
Deep Convolutional Neural Networks (DCNN) and Deep Recurrent Neural Networks (DRNN) are
examples of artificial neural networks with deep learning. They have been applied to fields such
as computer vision, automatic speech recognition or natural language processing, where they have
been shown to produce state-of-the-art results on multiples tasks, (see Table 1). The idea of building
DNNs is not new but there was a historical problem, called “vanishing gradient problem” [20]. It is
difficult to train these types of large networks with several layers when the backpropagation algorithm
is used to optimize the weights, because the gradients which propagate backwards rapidly diminish
in magnitude as the depth of the network increases, thus the weights in the early layers changes
very slowly [21]. DNNs have become the leading ML technology for a range of applications since
Geoffrey Hinton examined the issues around training large networks [22], and came up with a new
approach that had consequences for the cost of training of these networks [23,24]. Over the past decade,
a variety of algorithms and techniques have been developed to design and train different architectures
of DNN [25–31].
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Task (Year) Competition
Handwriting recognition (2009) MNIST (many), Arabic HWX (IDSIA)
Volumetric brain image segmentation (2009) Connectomics (IDSIA, MIT)
OCR in the Wild (2011) StreetView House Numbers (NYU and others)
Traffic si recognition (2011) GTSRB competition (IDSIA, NYU)
Human Action Recognition (2011) Hollywood II dataset (Stanford)
Breast cancer cell mitosis detection (2011) MITOS (IDSIA)
Object Recognition (2012) ImageNet competition (Toronto)
Scene Parsing (2012) Stanford bgd, SiftFlow, Barcelona datasets (NYU)
Speech Recognition (2012) Acoustic modeling (IBM and Google)
Asian handwriting recognition (2013) ICDAR competition (IDSIA)
Pedestrian Detection (2013) INRIA datasets and others (NYU)
Scene parsing from depth images (2013) NYU RGB-D dataset (NYU)
Playing Atari games (2013) 2600 Atari games (Google DeepMind Technologies)
Game of Go (2016) AlphaGo vs. Human World Champion(Google DeepMind Technologies)
Finally, GPUs were created to process graphics, especially for gaming and design. Some researchers
programmed GPUs using API, but this was a difficult task [33]. In 2007, NVIDIA published “Compute
Unified Device Architecture” (CUDA) [34], a programming language based on C to optimize GPGPU
application. CUDA allows researchers to make the most of the computing capabilities of GPUs for
parallel programming. Nowadays, almost every supercomputer in the TOP500 combines CPUs and
GPUs [35]. GPUs are beneficial for DL because the training of DNN is very intensive, so this training
can be parallelize with GPUs and a performance improvement greater than 10× can be obtained.
However, the ongoing work on design and construction of neuromorphic chips should be pointed out,
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as they represent a more efficient way to implement DNNs [36]. The neuromorphic chips attempt to
mimic the neuronal architectures present in the brain in order to reduce several orders of magnitude in
terms of energy consumption and to improve the performance of the information processing. However,
to run DNNs in a neuromorphic chip, they should be mapped in a spiking artificial neural network
(SNN) [37].
In this review, the main architectures of DNNs and their applications in pharmacology and
Bioinformatics are presented. The future need for neuromorphic hardware for DNNs is also discussed,
and the two most advanced chips that have already implemented DL are reviewed: IBM TrueNorth
and SpiNNaker. In addition, this work points out the importance of considering astrocytes in DNNs
and neuromorphic chips, given the proven importance of this type of glial cells in the brain.
2. Deep Artificial Neural Networks in Pharmacology and Bioinformatics
DL is a branch of ML that attempts to mimic the information processing in layers of neurons
in the neocortex. DNNs are trained to learn to recognize patterns in digital representations of
sounds, images, and other data. Usually, there is an unsupervised pre-training process, which
helps to initialize the weights. There are different DNN architectures, but in this review, only the
most representative types are briefly explained, we divided them in: Deep Auto-Encoder Networks
(DAENs), Deep Convolutional Neural Networks (DCNNs) and Deep Recurrent Neural Networks
(DRNNs). DAENs encompass Deep Feedforward Neural Networks (DFNNs), Deep Belief Networks
(DBNs), Deep Restricted Boltzmann Machines (DRBMs) and Deep Auto-Encoder Networks. There are
differences between these architectures, but they have in common big differences with respect
to DCNNs and DRNNs. These differences are highlighted, and some featured applications in
Pharmacology and Bioinformatics of each architecture are presented in Table 2. For a more detailed
analysis of the DL architecture, the differences, the training and the historical perspective, the reader
should refer to these reviews [25–31].
Table 2. Applications of different Deep Neural Networks (DNNs) architectures.




2.1. Deep Auto-Encoder Networks
As previously mentioned, the breakthrough of how to train DAENs was made by Hinton and
his team [23,24]. DAENs are models composed of multiple layers of neurons, trained one by one,
and could be stacked to as many as possible layers. Different DL architectures, such as DFNN, DBN,
DRBM and Deep Auto-Encoder Networks, were grouped together by us. There are some differences
between these architectures, but in general the idea of DAENs is stacking various layers of neurons,
to be pre-trained one by one, using each layer to train the next one. In the first layer, neurons learn
to recognize low level features. In an image, they could recognize basic forms such as lines, edges,
etc. The intermediate layers detect more abstract features, the ones detected depending on the data
set used to train the networks. For example, if a data set of faces is used, the intermediate layers can
recognize parts of the faces like eyes, mouth or ears. Finally, the last layer is trained to detect the most
abstract features, for example to recognize a person, a car or an animal in an image.
Usually, the training falls into two steps: the first step is layer-wise pre-training and the second
step is fine-tuning. Compared to how a neural network is traditionally trained, the first step can also
be seen as a clever way of initialization, whereas the second step can be as simple as backpropagation,
depending on the model to be trained.
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2.1.1. Pharmacology
A team led by George Dahl, from Hinton’s group, won the Merck Molecular Activity Challenge
organized by Kaggle in 2012, indicating the high potential of DL in drug design, and drawing
the attention of the pharmacology community. Merck’s data sets include on-target and ADME
(absorption, distribution, metabolism, and excretion) activities. Each molecule is represented by a list
of features, i.e., descriptors in QSAR nomenclature The DAEN have three hidden layers, each layer
having 2000 neurons, so the network has over 24 million tunable values. Generative unsupervised
pretraining and the procedure of dropout are used to avoid overfitting [38,39].
However, the small scale of Merck’s data set, 11,000 descriptors, 164,000 compounds, and 15 drug
targets, does not allow assessing the value of DL in drug target prediction. In 2014, Unterthiner et al.
analyzed the performance in a bigger data set, similar to the in-house data of pharmaceutical
companies [40]. The ChEMBL database has 13 million compound descriptors, 1.3 million compounds,
and 5000 drug targets. DAEN was compared to seven target prediction methods, including two
commercial predictors, three predictors deployed by pharmaceutical companies, and ML methods
that could scale to this data set. DAEN outperformed all the other methods and surpassed the
threshold to make VS possible. This showed the potential of DL to become a standard tool in industrial
drug design [40]. Unterthiner’s team won Tox21 Data Challenge within the “Toxicology in the 21st
Century” (Tox21) initiative launched by the United States agencies (NIH, EPA and FDA). The goal
of this challenge was to assess the performance of computational methods in predicting the toxicity
of chemical compounds. The DAEN used by Unterthiner’s team clearly outperformed all the other
participating methods [41]. In the first column of Table 3 this method is shown, and the area under
the Receiver Operating Characteristic curve (AUC) value is presented in the second column. The last
column shows the p-value of a paired Wilcoxon with the alternative hypothesis that the DAEN has on
average a larger AUC [40].
Table 3. Performance of target prediction methods analyzed by Unterthiner et al., in terms of mean
AUC (Area Under the Receiver Operating Characteristic curve) across targets [40].
Method AUC p-Value
Deep Auto-Encoder Network 0.830 –
Support Vector Machine 0.816 1.0 × 10−7
Binary Kernel Discrimination 0.803 1.9 × 10−67
Logistic Regression 0.796 6.0 × 10−53
k-Nearest neighbor 0.775 2.5 × 10−142
Pipeline Pilot Bayesian Classifier 0.755 5.4 × 10−116
Parzen-Rosenblatt 0.730 1.8 × 10−153
Similarity Ensemble Approach 0.699 1.8 × 10−173
Dahl et al. also performed an experiment on assay results deposited in PubChem (see Table 4);
they used a DAEN to learn a function that predicts activities of compounds for multiple assays at
the same time, which is called multi-task. Cellular and biochemical assays were included in the
dataset. Multiple related assays, for example assays for different families of cytochrome P450, were
used [42,43].
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Table 4. List of assays from Pubchem that were used for the study of Dahl et al. [42,43].
Article Identifier Assay Target/Goal Assay Type #Active #Inactive
1851(2c19) Cytochrome P450, family 2, subfamily C, polypeptide 19 Biochemical 5913 7532
1851(2d6) Cytochrome P450, family 2, subfamily D, polypeptide 6, isoform 2 Biochemical 2771 11,139
1851(3a4) Cytochrome P450, family 3, subfamily A, polypeptide 14 Biochemical 5266 7751
1851(1a2) Cytochrome P450, family 1, subfamily A, polypeptide 2 Biochemical 6000 7256
1851(2c9) Cytochrome P450, family 2, subfamily C, polypeptide 9 Biochemical 4119 8782
1915 Group A Streptokinase Expression Inhibition Cell 2219 1017
2358 Protein phosphatase 1, catalytic subunit, α isoform 3 Biochemical 1006 934
463213 Identify small molecule inhibitors of tim10-1 yeast Cell 4141 3235
463215 Identify small molecule inhibitors of tim10 yeast Cell 2941 1695
488912 Identify inhibitors of Sentrin-specific protease 8 (SENP8) Biochemical 2491 3705
488915 Identify inhibitors of Sentrin-specific protease 6 (SENP6) Biochemical 3568 2628
488917 Identify inhibitors of Sentrin-specific protease 7 (SENP7) Biochemical 4283 1913
488918 Identify inhibitors of Sentrin-specific proteases (SENPs)using a Caspase-3 Selectivity assay Biochemical 3691 2505
492992 Identify inhibitors of the two-pore domain potassium channel (KCNK9) Cell 2094 2820
504607 Identify inhibitors of Mdm2/MdmX interaction Cell 4830 1412
624504 Inhibitor hits of the mitochondrial permeability transition pore Cell 3944 1090
651739 Inhibition of Trypanosoma cruzi Cell 4051 1324
615744 NIH/3T3 (mouse embryonic fibroblast) toxicity Cell 3102 2306
652065 Identify molecules that bind r (CAG) RNA repeats Cell 2966 1287
In a series of empirical studies performed by Google and Stanford, several aspects of the use
of massively multi-task framework for VS were analyzed. To characterize each molecule, Extended
Connectivity Fingerprints (ECFP4) was used. This method decomposes each molecule in fragments
that are centered on a non-hydrogen atom. The fragments are labeled with an identifier, and all
the identifiers from a molecule are stored into vector of fixed length which represents the molecular
fingerprint. The results showed that both additional data and additional tasks improve accuracy.
Overall, 259 data sets, containing 37,800,000 experimental data points for 1,600,000 compounds,
were used [44].
2.1.2. Bioinformatics
Yanjun Qi et al. [45] created a DAEN to predict local properties of a protein based on its sequence.
Some of the properties predicted were the solvent accessible surface area, transmembrane topology,
DNA-binding residues, signal peptides and the secondary structure (see Figure 2). The DAEN used the
amino acid sequence as an input to predict the class labels. The method has three levels: first is a layer
for the feature extraction from the amino acid; the second is a layer for sequential feature extraction;
and, third, different layers of ANN. This method obtained state-of-the-art results [45].
DL architectures could be applied to predict the protein contact map. A group from the University
of California used a method with three levels of resolution steps. In the first step, coarse contacts and
orientations between elements of the secondary structure were predicted using 2D RNN. Subsequently,
to align these elements, a method based on energy was used, and the contact probabilities between
residues in strands or α-helices were predicted. In the third step, the information over space and
time was integrated to refine the predictions. The DL methods only achieve a 30% of accuracy,
but this represents an important improvement over other methods [46]. Eickholt and Cheng predicted
contacts between protein residues using a DAEN. The method was evaluated with the official Critical
Assessment of protein Structure Prediction (CASP) assessors, and with the cluster accuracy and
cluster count metrics. The predictor achieved better results predicting long-range contacts than
residue-residue contacts. For the top L/10 long-range contacts, the DAEN obtained a 66% of accuracy,
using a neighborhood of size 2 [47,48].
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distance [49]. A more complete study, published in Nature, showed the potential of DL for the 
prediction of the protein secondary structure, solvent accessibility and local backbone angles. To 
evaluate the DL method, a test data set with 1199 proteins was used. The DAEN predicted the 
secondary structure of the proteins with 82% accuracy, while the predicted and the real solvent 
surface area had a 76% correlation. The backbone angles had mean absolute errors between 8 and  
32 degrees [50]. DAENs can also be applied to assess the quality of the protein models, and obtain 
better results than the methods based in energy or scoring functions. A DL method was proposed by 
Nguyen et al., and it was called DL-Pro. The distance between two residues C-α atoms was used to 
create a representation that is independent of the orientation. A dataset from the CASP competition 
was used, and the DL-Pro achieve better results than the state-of-the-art methods [51]. 
Tan et al. applied DAENs to unsupervised feature construction and knowledge extraction to 
analyze the gene expression data from a breast cancer database. The constructed features extracted 
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Figure 2. Deep neural network architecture from Yanjun Qi et al. [45]. The input to the first layer is the
protein sequence represented by the single-letter amino acid code, for example the letter “A” (in green)
represents “Alanine”. This method uses a sliding window input {S1, S2 . . . Sk}, in this case k = 7.
he first layer consists a PSI- last feature o ule an an a ino aci e be ing o ule, the green
xes re rese t t e feature vector derived from the Ala ine in both modules. In the second layer,
the feature vectors are concatenated to facilitate identification of local sequence str ct re. i all t e
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In 2014, Lyons et al. published a paper about the use of a DAEN to predict the backbone Cα angles
and dihedrals based on the sequences of proteins. The mean absolute error for the predicted angles
was between 34 degrees for τ and 9 degrees for θ. The structures constructed of 10 residue fragments
based on the prediction, only differ 1.9 Å in average, measured with the root-mean-square distance [49].
A more complete study, published in Nature, showed the potential of DL for the prediction of the
protein secondary structure, solvent accessibility and local backbone angles. To evaluate the DL
method, a test data set with 1199 proteins was used. The DAEN predicted the secondary structure
of the proteins with 82% accuracy, while the predicted and the real solvent surface area had a 76%
correlation. The backbone angles had mean absolute errors between 8 and 32 degrees [50]. DAENs can
also be applied to assess the quality of the protein models, and obtain better results than the methods
based in energy or scoring functions. A DL method was proposed by Nguyen et al., and it was called
DL-Pro. The distance between two residues C-α atoms was used to create a representation that is
independent of the orientation. A dataset from the CASP competition was used, and the DL-Pro
achieve better results than the state-of-the-art methods [51].
Tan et al. applied DAENs to unsupervised feature construction and knowledge extraction to
analyze the gene expression data from a breast cancer database. The constructed features extracted
valuable information, from both a clinical and molecular perspective. This DAEN learnt to differentiate
samples with a tumor, the state of estrogen receptor, and molecular subtypes [52].
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DAENs were trained by a group from the University of California, Irvine, to annotate
the pathogenicity of genetic variants using training data consisting of 16M observed variants
and 49M simulated variants. This model improved considerably the performance of other methods,
around 15% [53].
The genes are very important in all biological processes, and nowadays their study has been
facilitated due to the DNA microarray technology. The expression of thousands of genes is measured
in one go, and this produces a huge amount of data. Gupta et al. proposed a DL architecture to learn
the structure in gene expression, with an application to gene clustering [54].
2.2. Deep Convolutional Neural Networks
The CNN are inspired by the structure of the visual cortex, discovered by Hubel and Wiessel [55],
which is formed by a complex pattern of neurons that are sensitive to small sub-regions, creating
receptive fields which act as local filters. The natural images, and other types of data, present a strong
correlation between nearby pixels, or input data points, and this relationship can be exploited by
these receptive fields to extract valuable patterns of features. The CNNs mimic this architecture and
have convolutional layers in which each neuron is connected with a subset of neurons of the previous
layer [56]. For example, in Figure 3, the neurons of the layer m are connected to 3 neurons from the
layer m-1, therefore each neuron only receives information from the sub-region of the input space.
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2.2.1. Pharmacology
DCNNs have been used to predict drug toxicity both at the atomic and molecular level.
Hughes et al. published a study that described a new system, used to predict the formation of reactive
epoxide metabolites. This method needs to be combined with additional tools in order to predict the
toxicity of drugs. For example, while this model predicts the formation of epoxides, it does not score
the reactivity of these epoxides (see Figure 5) [57].
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2.2.2. Bioinformatics 
DCNNs were used to predict the target of microRNA, which regulates genes associated with 
various diseases. Cheng et al. presented a DCNN that outperforms the existing target prediction 
algorithms and achieves significantly higher sensitivity, specificity and accuracy with values of 
88.43%, 96.44% and 89.98%, respectively [58]. DCNNs can also be applied to predict the sequence 
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Figure 5. This diagram represents a simplification of the structure of the epoxidation model, which was
made up of one input layer, two hidden layers, and two output layers. The actual model had several
additional nodes in the input and hidden layers. In the input layer, M represents the molecule input
node, B is the bond input node, and two atom input nodes (for each atom associated with the bond).
The bond epoxidation score (BES) quantifies the probability that the bond is a site of epoxidation based
in the input from the nodes of the first hidden layer (H1 and H2). The molecule epoxidation score
(MES) reflects the probability that the molecule will be epoxidized. This score is calculated with the
information from the all molecule-level descriptors and the BES. The bond network and the molecule
network are represented in orange and purple respectively [57].
Figure 6 shows how information flowed through the model, which was composed of one nput
layer, two hidden ayers, and two outpu layers. This model computed a molecule-level prediction for
each test molecule as well as predictions for each bond within that test molecule [57].
2.2.2. Bioinformatics
DCNNs were used to predict the target of microRNA, which regulate genes associated with
various diseases. Cheng et al. presented a DCNN that outperforms the existing target prediction
algorithms and achieves significantly higher sensitivity, specificity and accuracy with values of 88.43%,
96.44% and 89.98%, respectively [58]. DCNNs can also be applied to predict the sequence specificities
of DNA and RNA binding proteins. Alipanahi et al. developed a DL approach called DeepBind that
outperforms other state-of-the-art methods, even when training on in vitro data and testing on in vivo
data (see Figure 6) [59,60].
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2.3. Deep Recurrent Neural et orks
RNNs are a type of t at as rec rre t c ecti s, t s t e et ork represents a directed
cycle [61]. The RNNs can exhibit yna ic te poral behavior so they can process sequence of inputs
due to their internal e ory containing the recurrent connections. This makes them well suited
to be applied to tasks like handwriting recognition with unsegmented characters [62] or speech
recognition [63]. In a feedforward neural network, the depth is easured as the nu ber of layers
between the input and output. Unfortunately, this definition does not apply trivially to a recurrent
neural network (RNN) because of its temporal structure. A DRNN is a DNN with recurrent connections
in each layer [64,65]. When the network is updated, the information flows in both directions, up and
down, thus the sequential information can be learned (see Figure 7). The sequence of updates allows
the networks to integrate the information in different time scales, creating a temporal hierarchy.
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2.3.1. Pharmacology
Lusci et al. presented a brief overview of some applications of DRNNs aimed at the prediction of
molecular properties, such as aqueous solubility. Undirected cyclic graphs are usually used to describe
the molecules; however, the RNN typically uses directed acyclic graphs. Therefore, there was a need to
develop methods that would address the discrepancy by considering a set of DRNN associated with
all possible vertex-centered acyclic orientations of the molecular graph. The results obtained proved
that the DRNN performance is equal to or better than the other methods [66].
Over the past 50 years, drug-induced liver injury has cost a huge amount of money to the
pharmaceutical companies due to the drug withdrawal caused by this problem. DL methods has been
successfully applied to predict drug-induced liver injury Xu et al. compared different DL architectures
to predict drug-induced liver injury using four large data sets, and the best results were obtained by
a novel type of DRNN (see Figure 8). The structure of glycine is converted into a primary canonical
SMILES structure. Subsequently, each of the atoms in the SMILES structure is sequentially defined as a
root node. Finally, the information for all the other atoms is transferred along the shortest possible
paths. The best model achieved an accuracy of 86.9%, sensitivity of 82.5%, specificity of 92.9%, and area
under the curve (AUC) of 0.955 [67].
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faster, and more energy-efficient. This win-win scenario has driven the society to a digital era in 
which computers play a key role in almost every walk and aspect of our lives [22]. 
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in which case is obtained following the narrows [67].
2.3.2. Bioinformatics
DRNNs can be used to analyze biological sequence data, like predicting the subcellular location
of proteins. Sønderby et al. creat d a DRNN using only th protein sequence, and achieved 92%
of ccuracy in t redictio of the location of prot ins, utperforming the current state-of-the-art
algorithms. The performance was improved by the introduction of c nvolutional filte s and the
auth rs experimented with an attention mechanism that let the network focus on specific parts of the
protein [68].
3. Neuromorphic Chips
Since Alan Turing c ated the first computer, the progress in computer science has be n re arkable.
This progress was predicted by Gordon Moore in 1965, w o foretol that the number of transistors
that could be manufactured on a single silicon chip would double every 18 months to two years. It is
known as Moore’s Law, and over the past century it has been accomplished by making transistors
increasingly smaller. As CMOS transistors get smaller they become cheaper to make, faster, and more
energy-efficient. This win-win scenario has driven the society to a digital era in which computers play
a key role in almost every walk and aspect of our lives [22].
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However, Moore’s Law has limitations when it comes to shrinking transistors; there is a physical
limit in the size of the atom. At this scale, around 1 nm, the properties of the semi-conductor material
in the active region of a transistor are compromised by quantum effects like quantum tunneling.
In addition, there are also other limitations, such as the energy wall [69,70] and memory wall [71],
which denote the high power density and low memory bandwidth [72,73]. There are also economic
limitations, since the cost of designing a chip and the cost of building a fabrication facility are growing
alarmingly [74].
Trying to avoid some of these limitations, in the early years of this century, all of the major
microprocessor manufacturers moved from ever-faster clock speeds to multicore processors. Over the
past decade, instead of creating faster single-processor machines, new systems include more processors
per chip. Now we have CPUs with multicores, and GPUs with thousands of cores [22].
As already stated, DNNs have become the state-of-the-art algorithms of ML in many tasks.
However, both training and execution of large-scale DNNs require vast computing resources, leading
to high power requirements and communication overheads. The ongoing work on design and
construction of neuromorphic chips, the spike-based hardware platforms resulting from the book
about VLSI (Very Large Scale Integration) written by Lynn Conway and Carver Mead, and published
in the 1980s [75], offered an alternative by running DNNs with significantly lower power consumption.
However, the neuromorphic chips have to overcome hardware limitations in terms of noise and limited
weight precision, as well as noise inherent in the sensor signal [36]. Moreover, it is necessary to design
the structure, neurons, network input, and weights of DNN during training, to efficiently map those
networks to SNN in the neuromorphic chips (see Figure 9) [76].
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output neurons with the grey shapes (z and z’). The weights (w) to the neuron z are approximated 
using a Pseudo Random Number Generator (PRNG), resulting in the weights (w’) to the neuron z’ in 
the neuromorphic chip [74]. 
Focusing on projects involving neuromorphic hardware, the IBM TrueNorth chip [77] is one of 
the most impressive silicon implementation of DNNs. SpiNNaker, a project developed by the 
University of Manchester, also achieved excellent results implementing DNNs. Both [78] chips are 
digital, they compute the information using the binary system. However, some neuromorphic chips 
are analog, they consist of neuromorphic hardware elements where information is processed with 
analog signals; that is, they do not operate with binary values, as information is processed with 
continuous values [22]. In analog chips, there is no separation between hardware and software, 
because the hardware configuration is in charge of performing all the computation and can modify 
itself [79]. A good example is the HiCANN chip, developed at the University of Heidelberg, which 
uses wafer-scale above-threshold analog circuits [80]. There are also hybrid neuromorphic chips, like 
the Neurogrid from Stanford [81], which seek to make the most of each type of computing. It usually 
processes in analog and communicates in digital. This review will focus only on digital 
neuromorphic chips, the IBM TrueNorth and the SpiNNaker chip, because are the most advanced 
projects, obtained the best results implementing DNNs and published the highest number of 
technical papers. For further details about other projects and the differences between digital, analog 
and hybrid neuromorphic chips, the reader should refer to other reviews [82,83]. 
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TrueNorth (b). The input neurons are represented with the red and white shapes (x and x’), and the
output neurons with the grey shapes (z and z’). The weights (w) to the neuron z are approximated
using a Pseudo Random Number Generator (PRNG), resulting in the weights (w’) to the neuron z’ in
the neuromorphic chip [74].
Focu ing on proj cts involving n uromorphic hardware, the IBM T u North chip [77] is one
of the mos impressiv silicon implementation of DNNs. S iNNaker, a project developed by the
University of Manchester, als achieved excell nt results implementing DNNs. Both [78] chips are
digital, they compute the information using the binary system. However, some neuromorphic chips
are analog, they consist of neur m rphic hardware elements where information is processed with
analog signals; that is, they do not operate with binary values, as information is processed with
continuous values [22]. In analog chips, there is no separation between hardware and software,
because the hardware configuration is in charge of performing all the computation and can modify
itself [79]. A good example is the HiCANN chip, developed at the University of Heidelberg, which
uses wafer-scale above-threshold analog circuits [80]. There are also hybrid neuromorphic chips, like
the Neurogrid from Stanford [81], which seek to make the most of each type of computing. It usually
processes in analog and communicates in digital. This review will focus only on digital neuromorphic
chips, the IBM TrueNorth and the SpiNNaker chip, because are the most advanced projects, obtained
the best results implementing DNNs and published the highest number of technical papers. For further
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details about other projects and the differences between digital, analog and hybrid neuromorphic
chips, the reader should refer to other reviews [82,83].
3.1. TrueNorth International Business Machines (IBM)
The DARPA SyNAPSE (System of Neuromorphic Adaptive Plastic Scalable Electronics) initiative
selected and funded the proposal “Cognitive Computing via Synaptronics and Supercomputing (C2S2)”
of the Cognitive Computing Group at IBM Research-Almaden directed by Dharmendra Modha [77].
The project is based on the design and creation of a neuromorphic chip called TrueNorth, which has
a non-von Neumann architecture. It is characterized by modularity, parallelism and scalability. It is
inspired by the brain and its function, low power, and compact volume (see Figure 10). This chip can
be used to integrate spatio-temporal and real-time cognitive algorithms for different applications [84].
Currently in the final phase of the project, the researchers created a board with 16 TrueNorth
neuromorphic chips, capable of simulating 16 million neurons and four billion synapses. In 2015,
they assembled a system consisting of 128 chips and 128 million neurons [85]. The next goal is to
integrate 4096 chips into a single rack, which would represent four billion neurons and one trillion
synapses, consuming around 4 kW of power [86].
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The TrueNorth prototype was created in 2011 [87], and it was a neurosynaptic core with 256 
digital leaky integrate-and-fire neurons [37] and up to 256,000 synapses. The core is composed of 
memory and processor, and the communication takes places through all-or-none spike events. This 
allows an efficient implementation of a parallel asynchronous communication and Address Event 
Representation (AER) [88,89]. In this communication system, the neurons have a unique identifier, 
called address, and when a neuron spikes, the address is sent to other neurons. In 2012, Compass 
[90] was developed, a simulator to design neural networks to be implemented in the neuromorphic 
chip. Compass is a multi-threaded, massively parallel functional simulator and a parallel compiler. 
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(B) A network of neurosynaptic cores is inspired by the cortex’s two-dimensional sheet, the brain
regions are represented in different colors; (C) The multichip network is inspired by the long-range
connections between cortical regions shown from the macaque brain; (D–F) Structural scheme of the
core, chip and multi-chip level. The white shapes represent axons (inputs) and the grey shapes the
neurons (outputs); (G–I) Functional view at different level; (J–L) Image of the physical layout [77].
The TrueNorth prototype was created in 2011 [87], and it was a neurosynaptic core with 256 digital
leaky integrate-and-fi e neurons [37] and up to 256,000 synapses. Th core is composed of memory
and processor, and the communication takes places through all-or-none spike events. This allows an
efficient implementation of a parallel asynchronous communication and Address Event Representation
(AER) [88,89]. In this communication system, the neurons have a unique identifier, called address,
and when a neuron spikes, the address is sent to other neurons. In 2012, Compass [90] was developed,
a simulator to design neural networks to be implemented in the neuromorphic chip. Compass is
a multi-threaded, massively parallel functional simulator and a parallel compiler. It uses the C++
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language, sends spike events via MPI communication and uses OpenMP for thread-level parallelism.
A simulator for GPGPU [91] was also developed. Modha’s team simulated in 2007 the brain of a rat
in an IBM BlueGene/L supercomputer [92]. In 2010, they simulated a monkey’s brain [93] in IBM
BlueGene/P supercomputers from a network map of long-distance neural connections in the brain
obtained with 410 anatomical studies (Collation of Connectivity data on the Macaque brain). Later that
same year, they published the results of a simulation with Compass of 2048 billion neurosynaptic cores
and 5.4 × 1011 neurons and 1.37 × 1014 synapses [94]. The execution was 1542× times slower than real
time, and 1.5 million Blue Gene/Q supercomputers were needed.
A program in the TrueNorth chips consists of a definition of the inputs and outputs to the network
and the topology of the network of neurosynaptic cores. The parameters of the neurons and the
synaptic weights should be specified, as well as the inter- and intra-core connectivity [84,95].
The programming paradigm has four levels: The lowest level is the corelet, which represents an
abstraction of a TrueNorth program like a blackbox, only showing the inputs and outputs, and hiding
the other details. The next level is the Corelet Language which allows the creation and combination
of corelets. The validated corelets are included in the Corelet Library and can be reused to create
new corelets. This is like a repository and makes up the third level. The last level is the Corelet
Laboratory, a programming environment to develop new applications. It is integrated with Compass,
the TrueNorth simulator [84].
The corelet library has a collection of several functions that were implemented in the TrueNorth
chip verified and parameterized. Some examples are algebraic, logical and temporal functions,
convolutions, discrete Fourier transformations and many others. Using these functions different
algorithms were implemented in the TrueNorth chip, like CNN (see Figure 11) and Restricted
Bolztmann Machines for feature extraction, hidden Markov models, spectral content estimators, liquid
state machines, looming detectors, logistic regression, backpropagation and some others. The corelet
algorithm can be re-used in different applications, and there are different corelet implementations for
the same algorithm, showing the flexibility of the corelet construction [76,96].
TrueNorth was used in different applications, such as recognition of voices, composers, digits,
sequences, emotions or eyes. It was also used in collision avoidance and optical flow [96,97].
TrueNorth was also applied to bioinformatics by a group from the University of Pittsburgh,
who used the RS130 protein secondary structure data set to predict the local conformation of the
polypeptide chain and classified it into three classes: α helices, β-sheets, and coil [74].
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imple ented using the core’s synaptic array. The inputs are represented with white shapes, and the
grey triangles represent the neurons. The filter used in each case is implemented mapping the matrix
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(blue points) to target multiple core inputs, its output (orange points) must be replicated by neuron
copies, recruited from other neurons on the same core, or on extra cores if needed [76].
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3.2. SpiNNaker. University of Manchester
SpiNNaker is a project developed at the University of Manchester, whose principal investigator
is Steve B. Furber [78]. Within this project, chips, which contain many small CPUs, were produced.
Each CPU is designed to simulate about 1000 neurons, such as neural models of leaky integrate
and fire or Izhikevich’s model [37], which communicate spike events to other CPUs through a
network package. Each chip consists of 18 ARM968 processors, one of them acting as a processor
monitor. In 2015, a cabinet with 5760 chips was created, which can simulate 100 million point
neurons with approximately 1000 synapses per neuron [98]. The chips are connected with adjacent
chips by a two-dimensional toroidal mesh network and each chip has six network ports [99–101].
This system is expected to mimic the features of biological neural networks in various ways:
(1) native parallelism—each neuron is a primitive computational element within a massively parallel
system [102]; (2) spiking communications—the system uses AER, thus the information flow in a
network is represented as a time series of neural identifiers [103]; (3) event-driven behavior—to reduce
power consumption, the hardware was put into “sleep” mode, waiting for an event; (4) distributed
memory—this system uses memory local to each of the cores and an SDRAM local to each chip; and (5)
reconfigurability—the SpiNNaker architecture allows on-the-fly reconfiguration [104].
In order to configure a large number of cores, with millions of neurons and synapses,
PACMAN [105] was developed. It is a software tool that helps the user to create models, translate
and run in SpiNNaker. This allows the user to work with neural languages like PyNN [106] or
Nengo [107,108].
The SpiNNaker was created simulate real-time models, but the algorithms had to be defined in
the design process, therefore the models were static. In 2013, a paper [109] was published, in which a
novel learning rule was presented, describing its implementation into the SpiNNaker system, which
allows the use of the Neural Engineering Framework to establish a supervised framework to learn
both linear and non-linear functions. The learning rule belongs to the Prescribed Error Sensitivity class.
SpiNNaker supports two types of Deep Neural Networks:
• Deep Belief Networks: These networks of deep learning may be implemented, obtaining an
accuracy rate of 95% in the classification of the MNIST database of handwritten digits. Results of
0.06% less accuracy than with the software implementation are obtained, whereas the consumption
is only 0.3 W [36,110].
• Convolutional Neural Networks: This type of networks has the characteristic of sharing the same
value of weights for many neuron-to-neuron connections, which reduces the amount of memory
required to store the synaptic weights. A five-layer deep learning network is implemented to
recognize symbols which are obtained through a Dynamic Vision Sensor. Each ARM core can
accommodate 2048 neurons. The full chip could contain up to 32,000 neurons. A particular
ConvNet architecture was implemented in SpiNNaker for visual object recognition, like poker
card symbol classification [111].
Currently, there are no applications in pharmacology or bioinformatics, but SpiNNaker showed its
potential by implementing DNNs and DCNNs to visual recognition and robotics. In the future, it could
be trained in drug design, protein structure prediction or genomic, and other omics, data mining.
4. Discussion
As was pointed out, DNNs have become the state-of-the-art algorithms of ML in speech
recognition, computer vision, natural language processing and many other tasks (see Table 1) [26,27].
According to the results obtained, DNNs match the human capabilities, and even surpass them on
some tasks. Besides, the inner work of DNNs has similarities with the processing of information in
the brain. The pattern of activation of the artificial neurons is very similar to that observed in the
brain due to the sparse coding used, which may, for example, be applied to audio to obtain almost
Int. J. Mol. Sci. 2016, 17, 1313 16 of 26
exactly the same functions (see Figure 12). In the case of images, it was also shown that the functions
learned in each layers were similar to the patterns recognized by each layer of the human visual system
(V1 and V2).
This review analyzed applications in pharmacology and bioinformatics (see Table 2). DNNs can
be used in the drug discovery, design and validation processes, ADME properties prediction and QSAR
models. They also can be applied to the prediction of the structure of proteins and genomic, and other
omics, data mining. All these applications are very intensive from a computational perspective,
thus DNNs are very helpful because of their ability to deal with Big Data. Besides, DL complement the
use of other techniques, for example the quality and success of a QSAR model depend strictly on the
accuracy of input data, selection of appropriate descriptors and statistical tools, and most importantly
validation of the developed model. Feature extraction from the descriptor patterns is the decisive step
in the model development process [4].
Regarding architectures, nowadays, the largest DNN has millions of artificial neurons and
around 160 billion parameters [112]. Building large networks will improve the results of DL, but the
development of new DL architectures is a very interesting way to enhance the capabilities of the
networks. For example, the latest DRNN architectures with “memory” show excellent results in
natural language processing, one of the hardest task for ML [26–29,31].
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molded the brain for millions of years, creating a highly complex process of development. This was
remarkably pointed out by Andrew Ng, neurons in the brain are very complex structures, and after a
century of study the researchers still are not able to fully understand how they work. The neurons in
the ANN are simple mathematical functions that attempt to mimic the biological neurons. However,
the artificial neurons only reach the level of loose inspiration. Consequently, reaching the level of
human brain computation will not necessarily mean that the future computers will surpass human
intelligence. In our opinion, the advances in understanding the human brain will be more important
in order to make a breakthrough that will lead us to new types of DNNs.
In this regard, it should be pointed out that the human brain is composed of neurons, but also
glial cells, and there is almost the same number of both [121]. More importantly, over the past decade,
it has been proven that astrocytes, a type of glial cells of the central nervous system, actively participate
in the information processing in the brain. There are many works published over the past two decades
on multiple modes of interaction between neurons and glial cells [122–125]. Many studies suggest the
existence of bidirectional communication between neurons and astrocytes, a type of glial cells of the
central nervous system [126,127]. This evidence has led to the proposal of the concept of tripartite
synapse [128], formed by three functional elements: presynaptic neuron, postsynaptic neuron and
perisynaptic astrocyte (see Figure 13).
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perisynaptic astrocyte (astrocyte process). The presynaptic neuron release neurotransmitters that
are received by the postsynaptic neuron or the perisynaptic astrocyte [129].
The relation between these three elements is very complex and there are different pathways
of communication: astrocytes can respond to different neurotransmitters (glutamate, GABA,
acetylcholine, ATP or noradrenaline) [130] liberating an intracellular Ca2+ signal, known as calcium
wave that could be transmitted to other astrocytes through GAP junctions. In addition, astrocytes
may release gliotransmitters that activate presynaptic and postsynaptic neuronal receptors, leading
to a regulation of the neural excitability, synaptic transmission, plasticity and memory [131,132].
The possibility of a quad-partite synapse, in which microglia are engaged [133], has recently
been proposed.
In addition, there is interesting scientific evidence that suggests the important role of glial cells in
the intelligence of the species. Although there are no major differences between neurons of different
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species of mammals, the glial cells have evolved in the evolutionary chain. For example, a rodent’s
astrocytes may include between 20,000 and 120,000 synapses, while a human’s may include up to
two million synapses [134,135]. Not only should the complexity of the astrocytes be pointed out,
but also their size. Human astrocytes have a volume 27 times greater than the same cells in the mouse’s
brain [134,135]. Besides, the ratio of glial cells to neurons increased along the evolutionary chain.
One of the most striking research events has been the discovery of a single glial cell for every 30 neurons
in the leech. This single glial cell receives neuronal sensory input and controls neuronal firing to the
body. As we move up the evolutionary ladder, in a widely researched worm, Caenorhabditis elegans,
glia cells are 16% of the nervous system. The fruit fly’s brain has about 20% glia. In rodents such as
mice and rats, glia cells make up 60% of the nervous system. The nervous system of the chimpanzee
has 80% glia, while the human 90%. The ratio of glia to neurons increases with our definition of
intelligence [123]. The number of astrocytes per neuron also increases as we move up the evolutionary
ladder, humans having around 1.5 astrocytes per neuron [136].
Furthermore, the ratio of glial cells to neurons varies in different brain regions. In the cerebellum,
for instance, there are almost five times more neurons than astrocytes. However, in the cortex, there are
four times more glial cells than neurons [121,137]. All these data suggest that the more complex the
task, performed, by either an animal or a brain region, the greater the number of glial cells involved.
Currently, there are two projects aimed at implementing astrocytes in neuromorphic chips,
one is BioRC developed by the University of Southern California [138–141] and the other project is
carried out by the University of Tehran and University of Kermanshah, Iran [142–144]. Moreover,
the RNASA-IMEDIR group from the University of A Coruña developed an Artificial Neuron-Glia
Network (ANGN) incorporating two different types of processing elements: artificial neurons and
artificial astrocytes. This extends classical ANN by incorporating recent findings and suppositions
regarding the way information is processed via neural and astrocytic networks in the most evolved
living organisms [145–149]. In our opinion, neurons are specialized in transmission and information
processing, whereas glial cells in processing and modulation. Besides, glial cells play a key role in the
establishment of synapses and neural architecture. That is why it would be interesting to combine
these two types of elements in order to create a Deep Artificial Neuron–Astrocyte Network (DANAN).
5. Conclusions
DNNs represent a turning point in the history of Artificial Intelligence, achieving results that
match, or even surpass the human capabilities in some tasks. These results motivated major companies
like Google, Facebook, Microsoft, Apple and IBM to focus their research on this field. Nowadays,
DNNs are used every day unknowingly, since in our smartphones there are numerous applications
based on Deep Learning. For example, some cameras use a DNN to perform face recognition, while
others employ a voice recognition piece of software, which is also based on DL. There are many other
applications with DNNs that perform state-of-the-art results.
Pharmacology and bioinformatics are very interesting fields for DL application, because there
is an exponential growth of the data. There is a huge potential in applying DNNs in the process of
drug discovery, design and validation that could improve performance and greatly reduce the costs.
However, the most promising area is genomics, and other omics, like proteomics, transcriptomics or
metabolomics. These types of data are so complex that it is almost impossible for humans to extract
valuable insights. Thus, the use of DNNs would be necessary to extract the information useful to
understand the relationships between the DNA, epigenetics variations, and different diseases.
Consequently, scientific and economic interests have led to the creation of numerous R&D projects
to keep improving DNNs. Developing new hardware architectures is also important in order to
improve the current CPUs and GPUs. The neuromorphic chips represent a great opportunity to
reduce the energy consumption and enhance the capabilities of DNNs, being very helpful to process a
vast volume of information generated by the Internet of Things. Besides, using neuromorphic chips
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may lead to the creation of a large-scale system that would attempt to represent an Artificial General
Intelligence, moving from the current Artificial Narrow Intelligence.
Finally, it would be of great interest to create networks with two types of processing elements,
to create DANANs that will work more similarly to the human brain. This should be considered a very
resourceful way of improving the current systems, and our group’s objective is to implement this first
type of DANAN. This type of networks will consider the proven capabilities of the glial cells in the
processing of information, regulation of the neural excitability, synaptic transmission, plasticity and
memory, to create more complex systems that could bring us closer to an Artificial General Intelligence.
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Abbreviations
ADME Absorption, Distribution, Metabolism, and Excretion
AER Address Event Representation
ANGN Artificial Neuron-Glia Networks
ANN Artificial Neural Networks
AUC Area Under the Receiver Operating Characteristic Curve
CASP Critical Assessment of protein Structure
CNN Convolutional Neural Networks
CPU Central Processing Unit
CUDA Compute Unified Device Architecture
DAEN Deep Auto-Encoder Networks
DANAN Deep Artificial Neuron–Astrocyte Networks
DBN Deep Belief Networks
DCNN Deep Convolution Neural Networks
DFNN Deep Feedforward Neural Networks
DL Deep Learning
DNN Deep Artificial Neural Networks
DBM Deep Boltzmann Machines
DRNN Deep Recurrent Neural Networks
ECFP4 Extended Connectivity Fingerprints
GPGPUs General-Purpose Graphical Processing Units
GPU Graphical Processing Unit
ML Machine Learning
QSAR Quantitative Structure–Activity Relationship
QSPkR Quantitative Structure–Pharmacokinetic Relationship
QSPR Quantitative Structure–Property Relationships
QSTR Quantitative Structure–Toxicity Relationship
SANN Spiking Artificial Neural Network
SVM Support Vector Machines
VLSI Very Large Scale Integration
VS Virtual Screening
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